Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 18 | 2019 | 70 | 1.360 |
Why?
|
| Orbital Diseases | 2 | 2019 | 21 | 0.720 |
Why?
|
| Ecchymosis | 1 | 2019 | 2 | 0.670 |
Why?
|
| Eye Hemorrhage | 1 | 2019 | 2 | 0.660 |
Why?
|
| Cavernous Sinus | 1 | 2019 | 15 | 0.660 |
Why?
|
| Conjunctival Diseases | 1 | 2019 | 7 | 0.660 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2019 | 33 | 0.640 |
Why?
|
| Keratitis | 9 | 2019 | 22 | 0.550 |
Why?
|
| Corneal Diseases | 7 | 2021 | 33 | 0.490 |
Why?
|
| Visual Acuity | 9 | 2021 | 198 | 0.470 |
Why?
|
| Keratoplasty, Penetrating | 7 | 2011 | 14 | 0.470 |
Why?
|
| Acanthamoeba Keratitis | 3 | 2021 | 8 | 0.460 |
Why?
|
| Incontinentia Pigmenti | 1 | 2009 | 2 | 0.350 |
Why?
|
| Eye Infections, Bacterial | 5 | 2019 | 15 | 0.350 |
Why?
|
| Photorefractive Keratectomy | 2 | 2000 | 4 | 0.320 |
Why?
|
| Corneal Stroma | 3 | 2021 | 13 | 0.310 |
Why?
|
| Conjunctiva | 2 | 2018 | 19 | 0.300 |
Why?
|
| Pseudomonas Infections | 6 | 1995 | 99 | 0.280 |
Why?
|
| Keratoconus | 4 | 2021 | 11 | 0.250 |
Why?
|
| Acanthamoeba | 2 | 2021 | 17 | 0.230 |
Why?
|
| Ciprofloxacin | 5 | 1995 | 29 | 0.230 |
Why?
|
| Limbus Corneae | 1 | 2003 | 1 | 0.220 |
Why?
|
| Phosphorylcholine | 2 | 2021 | 28 | 0.220 |
Why?
|
| Ophthalmic Solutions | 4 | 2018 | 16 | 0.220 |
Why?
|
| Wound Healing | 2 | 1996 | 359 | 0.210 |
Why?
|
| Collagen | 6 | 1991 | 293 | 0.200 |
Why?
|
| Debridement | 2 | 2000 | 57 | 0.190 |
Why?
|
| Contact Lenses, Extended-Wear | 1 | 2000 | 2 | 0.190 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 6 | 0.190 |
Why?
|
| Punctures | 1 | 2000 | 29 | 0.190 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2000 | 24 | 0.190 |
Why?
|
| Administration, Topical | 10 | 2005 | 96 | 0.190 |
Why?
|
| Stem Cells | 1 | 2003 | 372 | 0.180 |
Why?
|
| Anterior Chamber | 4 | 1990 | 9 | 0.180 |
Why?
|
| Eye Infections, Parasitic | 1 | 2019 | 4 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 511 | 0.180 |
Why?
|
| Rabbits | 15 | 1996 | 638 | 0.170 |
Why?
|
| Micrococcaceae | 1 | 2019 | 3 | 0.170 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2019 | 50 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2003 | 688 | 0.160 |
Why?
|
| Keratoconjunctivitis | 1 | 2018 | 5 | 0.160 |
Why?
|
| Orbit | 1 | 2019 | 38 | 0.160 |
Why?
|
| Pseudolymphoma | 1 | 2018 | 9 | 0.160 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2018 | 10 | 0.160 |
Why?
|
| Prednisolone | 3 | 2018 | 40 | 0.150 |
Why?
|
| Rhinosporidiosis | 1 | 1997 | 1 | 0.150 |
Why?
|
| Descemet Stripping Endothelial Keratoplasty | 2 | 2021 | 19 | 0.140 |
Why?
|
| Biomarkers | 1 | 2003 | 1755 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1215 | 0.140 |
Why?
|
| Humans | 38 | 2021 | 89063 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 262 | 0.130 |
Why?
|
| Lenses, Intraocular | 5 | 1986 | 12 | 0.130 |
Why?
|
| Middle Aged | 14 | 2019 | 25863 | 0.130 |
Why?
|
| Corneal Injuries | 2 | 1994 | 10 | 0.120 |
Why?
|
| Aqueous Humor | 4 | 1990 | 24 | 0.120 |
Why?
|
| Female | 22 | 2019 | 46011 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 270 | 0.120 |
Why?
|
| Giant Cell Arteritis | 1 | 2014 | 5 | 0.120 |
Why?
|
| Retinal Artery Occlusion | 1 | 2014 | 12 | 0.120 |
Why?
|
| Child | 7 | 2009 | 7149 | 0.120 |
Why?
|
| Blindness | 1 | 2014 | 39 | 0.120 |
Why?
|
| Neurons | 1 | 2003 | 1580 | 0.120 |
Why?
|
| Fluoresceins | 2 | 1991 | 43 | 0.120 |
Why?
|
| Biopsy | 3 | 2018 | 1182 | 0.120 |
Why?
|
| Cyclosporins | 2 | 1990 | 58 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1994 | 105 | 0.110 |
Why?
|
| Corneal Transplantation | 2 | 1991 | 9 | 0.110 |
Why?
|
| Glucocorticoids | 4 | 2018 | 357 | 0.100 |
Why?
|
| Norfloxacin | 2 | 1991 | 5 | 0.100 |
Why?
|
| Endothelium, Corneal | 1 | 2011 | 19 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 2 | 2018 | 306 | 0.090 |
Why?
|
| Contact Lenses | 4 | 1990 | 7 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 4 | 2019 | 786 | 0.090 |
Why?
|
| Epithelium, Corneal | 2 | 2000 | 13 | 0.090 |
Why?
|
| Scleritis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Lasers, Excimer | 2 | 2000 | 5 | 0.080 |
Why?
|
| Tobramycin | 5 | 1995 | 9 | 0.080 |
Why?
|
| Tomography, Optical Coherence | 2 | 2021 | 136 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 6 | 1995 | 202 | 0.080 |
Why?
|
| Brain | 1 | 2019 | 2281 | 0.080 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2008 | 5 | 0.080 |
Why?
|
| Graft Rejection | 2 | 2011 | 1064 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1591 | 0.070 |
Why?
|
| Random Allocation | 6 | 1994 | 328 | 0.070 |
Why?
|
| Orbital Neoplasms | 1 | 1987 | 17 | 0.070 |
Why?
|
| Fibroma | 1 | 1987 | 33 | 0.070 |
Why?
|
| Astigmatism | 6 | 1998 | 10 | 0.070 |
Why?
|
| Adult | 11 | 2021 | 26507 | 0.070 |
Why?
|
| Abscess | 1 | 1987 | 94 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3443 | 0.070 |
Why?
|
| Biological Dressings | 3 | 1990 | 5 | 0.070 |
Why?
|
| Colony Count, Microbial | 5 | 1995 | 46 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 529 | 0.070 |
Why?
|
| Male | 15 | 2021 | 42251 | 0.070 |
Why?
|
| Skin | 1 | 2009 | 581 | 0.070 |
Why?
|
| Antiprotozoal Agents | 2 | 2019 | 32 | 0.070 |
Why?
|
| Nocardia asteroides | 1 | 2005 | 2 | 0.070 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2005 | 2 | 0.070 |
Why?
|
| Nocardia Infections | 1 | 2005 | 5 | 0.070 |
Why?
|
| Family | 1 | 2008 | 325 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2019 | 682 | 0.070 |
Why?
|
| Postoperative Complications | 5 | 2011 | 2275 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 6 | 1996 | 141 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2003 | 3717 | 0.060 |
Why?
|
| Infant | 2 | 2003 | 3147 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 1985 | 27 | 0.060 |
Why?
|
| Drug Therapy, Combination | 4 | 2010 | 783 | 0.060 |
Why?
|
| Sinusitis | 1 | 1987 | 214 | 0.060 |
Why?
|
| Incidence | 2 | 2000 | 1592 | 0.060 |
Why?
|
| Pharmaceutical Vehicles | 3 | 1994 | 10 | 0.060 |
Why?
|
| Adolescent | 4 | 2010 | 9237 | 0.060 |
Why?
|
| Nestin | 1 | 2003 | 18 | 0.060 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2003 | 26 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 1985 | 221 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2003 | 35 | 0.060 |
Why?
|
| Ectoderm | 1 | 2003 | 31 | 0.060 |
Why?
|
| Corneal Opacity | 2 | 2001 | 2 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 159 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 786 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2003 | 403 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 396 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 261 | 0.050 |
Why?
|
| Recurrence | 2 | 2005 | 1140 | 0.050 |
Why?
|
| Amblyopia | 1 | 2001 | 7 | 0.050 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2001 | 8 | 0.050 |
Why?
|
| Prednisone | 2 | 2014 | 258 | 0.050 |
Why?
|
| Corneal Edema | 1 | 2021 | 6 | 0.050 |
Why?
|
| Animals | 15 | 1996 | 27317 | 0.050 |
Why?
|
| Corneal Topography | 2 | 2017 | 10 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2021 | 43 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 287 | 0.050 |
Why?
|
| Ointments | 1 | 2000 | 12 | 0.050 |
Why?
|
| Aged | 6 | 2011 | 19077 | 0.050 |
Why?
|
| Melanoma | 1 | 1985 | 467 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 6777 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2003 | 443 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 1994 | 901 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2019 | 5 | 0.040 |
Why?
|
| DNA, Protozoan | 1 | 2019 | 16 | 0.040 |
Why?
|
| Fluorescein Angiography | 2 | 2014 | 96 | 0.040 |
Why?
|
| Keratitis, Dendritic | 2 | 1990 | 13 | 0.040 |
Why?
|
| Equipment Design | 1 | 2000 | 415 | 0.040 |
Why?
|
| Suture Techniques | 2 | 1990 | 140 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 841 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 277 | 0.040 |
Why?
|
| Benzalkonium Compounds | 1 | 2018 | 2 | 0.040 |
Why?
|
| Preservatives, Pharmaceutical | 1 | 2018 | 10 | 0.040 |
Why?
|
| Loteprednol Etabonate | 1 | 2018 | 2 | 0.040 |
Why?
|
| Administration, Ophthalmic | 1 | 2018 | 9 | 0.040 |
Why?
|
| Simplexvirus | 2 | 1990 | 151 | 0.040 |
Why?
|
| Antigens, CD20 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2018 | 39 | 0.040 |
Why?
|
| Anesthetics | 1 | 2018 | 53 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2880 | 0.040 |
Why?
|
| Glaucoma | 2 | 2011 | 33 | 0.040 |
Why?
|
| Rhinosporidium | 1 | 1997 | 1 | 0.040 |
Why?
|
| Epithelium | 2 | 1996 | 325 | 0.040 |
Why?
|
| New York | 1 | 1997 | 72 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1241 | 0.040 |
Why?
|
| Optic Nerve | 3 | 1985 | 36 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 249 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 242 | 0.030 |
Why?
|
| Iontophoresis | 3 | 1990 | 9 | 0.030 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 1985 | 12 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 1652 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 948 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 13 | 0.030 |
Why?
|
| Temporal Arteries | 1 | 2014 | 9 | 0.030 |
Why?
|
| Lens, Crystalline | 2 | 1986 | 69 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2014 | 42 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 64 | 0.030 |
Why?
|
| Fluorophotometry | 2 | 1991 | 3 | 0.030 |
Why?
|
| Fluorescein | 2 | 1991 | 16 | 0.030 |
Why?
|
| Carotid Artery, Internal | 1 | 2014 | 68 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 434 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 738 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 192 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2014 | 115 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2011 | 9003 | 0.030 |
Why?
|
| Myopia | 2 | 1990 | 10 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1985 | 447 | 0.030 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 1991 | 3 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 1990 | 1239 | 0.020 |
Why?
|
| Time Factors | 2 | 1994 | 5320 | 0.020 |
Why?
|
| Graft vs Host Reaction | 1 | 1991 | 15 | 0.020 |
Why?
|
| Connective Tissue | 1 | 1991 | 23 | 0.020 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2011 | 12 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1991 | 124 | 0.020 |
Why?
|
| Plant Oils | 1 | 1990 | 9 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 1990 | 32 | 0.020 |
Why?
|
| Olive Oil | 1 | 1990 | 8 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 155 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 287 | 0.020 |
Why?
|
| Quinolones | 1 | 1990 | 60 | 0.020 |
Why?
|
| Aphakia | 1 | 1990 | 10 | 0.020 |
Why?
|
| Virus Activation | 1 | 1990 | 41 | 0.020 |
Why?
|
| Bandages | 1 | 1990 | 41 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2011 | 90 | 0.020 |
Why?
|
| Timolol | 1 | 1989 | 2 | 0.020 |
Why?
|
| Trifluridine | 1 | 1989 | 6 | 0.020 |
Why?
|
| Thymidine | 1 | 1989 | 59 | 0.020 |
Why?
|
| Iris Diseases | 2 | 1986 | 6 | 0.020 |
Why?
|
| Ophthalmology | 1 | 1989 | 43 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2009 | 65 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 1995 | 2362 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1990 | 229 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 598 | 0.020 |
Why?
|
| Dimethylallyltranstransferase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Ciliary Body | 2 | 1985 | 7 | 0.020 |
Why?
|
| Eye Diseases | 2 | 1985 | 58 | 0.020 |
Why?
|
| Iris | 2 | 1985 | 5 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2008 | 130 | 0.020 |
Why?
|
| Point Mutation | 1 | 2008 | 245 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 338 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 1991 | 364 | 0.020 |
Why?
|
| Detergents | 1 | 1986 | 34 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 3 | 1990 | 75 | 0.020 |
Why?
|
| Ultrasonics | 1 | 1986 | 39 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1986 | 60 | 0.020 |
Why?
|
| Imipenem | 1 | 2005 | 2 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2005 | 8 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 969 | 0.020 |
Why?
|
| Fluoroquinolones | 1 | 2005 | 22 | 0.020 |
Why?
|
| Lasers | 1 | 1986 | 107 | 0.020 |
Why?
|
| Eye Injuries | 1 | 1985 | 14 | 0.020 |
Why?
|
| Choroid Neoplasms | 1 | 1985 | 6 | 0.020 |
Why?
|
| Optic Disk | 1 | 1985 | 13 | 0.020 |
Why?
|
| Lens Capsule, Crystalline | 1 | 1985 | 11 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 209 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1990 | 270 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 1985 | 18 | 0.020 |
Why?
|
| Quinolines | 1 | 2005 | 91 | 0.020 |
Why?
|
| Hamartoma | 1 | 1984 | 34 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 1985 | 296 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1487 | 0.010 |
Why?
|
| Risk Factors | 2 | 2011 | 5466 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3027 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 2657 | 0.010 |
Why?
|
| Methylmethacrylates | 2 | 1990 | 8 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 6288 | 0.010 |
Why?
|
| Surgical Instruments | 2 | 1989 | 57 | 0.010 |
Why?
|
| Eye | 2 | 1989 | 111 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1995 | 344 | 0.010 |
Why?
|
| Absorption | 1 | 1991 | 25 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1990 | 4273 | 0.010 |
Why?
|
| Biological Availability | 1 | 1991 | 92 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1991 | 15 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 181 | 0.010 |
Why?
|
| Refractive Errors | 1 | 1990 | 4 | 0.010 |
Why?
|
| Denervation | 1 | 1990 | 24 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1991 | 105 | 0.010 |
Why?
|
| R Factors | 1 | 1989 | 6 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1990 | 83 | 0.010 |
Why?
|
| Conjugation, Genetic | 1 | 1989 | 23 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1990 | 126 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1991 | 183 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 149 | 0.010 |
Why?
|
| Delayed-Action Preparations | 1 | 1988 | 110 | 0.000 |
Why?
|
| Cell Survival | 1 | 1991 | 982 | 0.000 |
Why?
|
| Transplantation, Homologous | 1 | 1991 | 995 | 0.000 |
Why?
|
| Graft Survival | 1 | 1991 | 898 | 0.000 |
Why?
|
| Uvea | 1 | 1986 | 1 | 0.000 |
Why?
|
| Suppuration | 1 | 1986 | 9 | 0.000 |
Why?
|
| Conjunctivitis | 1 | 1986 | 6 | 0.000 |
Why?
|
| Sterilization | 1 | 1986 | 8 | 0.000 |
Why?
|
| Drug Contamination | 1 | 1986 | 12 | 0.000 |
Why?
|
| Enterotoxins | 1 | 1986 | 21 | 0.000 |
Why?
|
| Uveitis | 1 | 1986 | 31 | 0.000 |
Why?
|
| Esotropia | 1 | 1985 | 1 | 0.000 |
Why?
|
| Bacterial Toxins | 1 | 1986 | 114 | 0.000 |
Why?
|
| Uveal Diseases | 1 | 1985 | 3 | 0.000 |
Why?
|
| Pupil | 1 | 1985 | 20 | 0.000 |
Why?
|
| Methods | 1 | 1985 | 151 | 0.000 |
Why?
|
| Biodegradation, Environmental | 1 | 1985 | 18 | 0.000 |
Why?
|
| Fundus Oculi | 1 | 1984 | 33 | 0.000 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1985 | 19 | 0.000 |
Why?
|
| Escherichia coli Proteins | 1 | 1986 | 183 | 0.000 |
Why?
|
| Melanocytes | 1 | 1984 | 57 | 0.000 |
Why?
|
| Radiation Injuries | 1 | 1986 | 160 | 0.000 |
Why?
|
| Intraocular Pressure | 1 | 1984 | 57 | 0.000 |
Why?
|
| Intraoperative Complications | 1 | 1985 | 188 | 0.000 |
Why?
|
| Macular Edema | 1 | 1984 | 50 | 0.000 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 162 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1990 | 1223 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1985 | 278 | 0.000 |
Why?
|
| Inflammation | 1 | 1985 | 971 | 0.000 |
Why?
|